lomustine has been researched along with mitoxantrone in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Frank, N; Osswald, H | 1 |
| Hagenbeek, A; Löwenberg, B; Michiels, J; Ruit, JB; Sizoo, W; Verhoef, GE; Wielenga, JJ | 1 |
| Bernasconi, C | 1 |
| Allen, PK; Besa, P; Cabanillas, F; Cox, JD; Hagemeister, FB; McLaughlin, P; Preti, A; Rodriguez, A; Swan, F | 1 |
| Agarwal, V; Ashigbi, MY; Bello, J; Venkatraj, U; Wiernik, PH | 1 |
| Boiardi, A; Broggi, G; Eoli, M; Pozzi, A; Salmaggi, A; Silvani, A | 1 |
| Abebe, L; Adiga, GU; Wiernik, PH | 1 |
| Alexandrescu, DT; Dutcher, JP; Karri, S; Wiernik, PH | 1 |
| Aguila, B; Allouche, S; Balboni, G; Borsodi, A; Boulouard, M; Coulbault, L; Davis, A; Jauzac, P; Léveillé, F; Salvadori, S; Tóth, G | 1 |
| Fukui, T; Goto, M; Hakiri, S; Hashimoto, K; Ito, T; Kawaguchi, K; Mori, S; Nakamura, S; Ozeki, N; Yokoi, K | 1 |
| Chen, M; Chen, X; Fang, F; Guo, J; Han, L; Hung, MC; Kuang, X; Li, H; Li, J; Liang, L; Liu, H; Liu, J; Ma, F; Peng, C; Su, J; Sun, L; Tao, J; Weng, L; Xie, Y; Xie, Z; Xu, X; Yang, N; Ye, Y; Zhang, J; Zhang, X; Zhang, Y; Zhao, S | 1 |
3 review(s) available for lomustine and mitoxantrone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Etoposide: fifteen years experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Etoposide; Hodgkin Disease; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Lomustine; Melphalan; Mitoxantrone | 1989 |
Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bowen's Disease; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Fatal Outcome; Female; Hodgkin Disease; Humans; Immunophenotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Lomustine; Male; Middle Aged; Mitoxantrone; Neoplasms, Multiple Primary; Neoplastic Stem Cells; Prednisone; Prognosis; Reed-Sternberg Cells; Remission Induction; Skin Neoplasms; Splenectomy; Tumor Virus Infections; Vidarabine; Vinblastine; Vincristine | 2003 |
12 other study(ies) available for lomustine and mitoxantrone
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Sacrosine- and prolinedithiocarbamate pretreatment increases the therapeutic efficacy of doxorubicin, methotrexate, teniposide, mitoxantrone or cyclohexylchloroethylnitrosourea in leukemia L1210.
Topics: Animals; Antineoplastic Agents; Cysteine; Doxorubicin; Drug Synergism; Female; Leukemia L1210; Lomustine; Methotrexate; Mice; Mice, Inbred DBA; Mitoxantrone; Proline; Sarcosine; Teniposide; Thiocarbamates | 1990 |
Phase II study of lomustine, cytarabine, mitoxantrone, and prednisone (CAMP) combination chemotherapy for doxorubicin-resistant intermediate- and high-grade malignant non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Doxorubicin; Drug Evaluation; Drug Resistance; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Remission Induction; Survival Rate | 1990 |
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Remission Induction; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Intracranial Hodgkin's disease in two patients with familial Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Family Health; Fatal Outcome; Hodgkin Disease; Humans; Lomustine; Male; Mitoxantrone; Recurrence; Remission Induction; Vinblastine | 1997 |
Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Drug Evaluation; Glioblastoma; Humans; Injections, Spinal; Lomustine; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Procarbazine; Radiotherapy, Adjuvant; Reoperation; Survival Analysis; Treatment Outcome; Vincristine | 1999 |
Mitoxantrone, vinblastine and CCNU: long-term follow-up of patients treated for advanced and poor-prognosis Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Follow-Up Studies; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Remission Induction; Treatment Outcome; Vinblastine | 2006 |
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.
Topics: Animals; Antidepressive Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Binding, Competitive; Cell Line, Tumor; Cytarabine; Depression; Desensitization, Immunologic; Disease Models, Animal; Drug Administration Schedule; Drug Tolerance; Endocytosis; Humans; Lomustine; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitoxantrone; Neuroblastoma; Oligopeptides; Phosphorylation; Prednisone; Receptors, Opioid, delta; Signal Transduction; Swimming | 2007 |
Multimodality therapy for thymoma patients with pleural dissemination.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Female; Humans; Induction Chemotherapy; Lomustine; Male; Middle Aged; Mitoxantrone; Myasthenia Gravis; Neoplasm Recurrence, Local; Pleural Diseases; Pneumonectomy; Prednisone; Retrospective Studies; Survival Rate; Thymoma; Thymus Neoplasms | 2019 |
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis.
Topics: Activating Transcription Factor 3; Adenosine A1 Receptor Antagonists; Adult; Aged; Animals; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cytarabine; Female; Humans; Lomustine; Lung Neoplasms; Male; Melanoma; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Mitoxantrone; Prednisone; Receptor, Adenosine A1; Tumor Escape; Xenograft Model Antitumor Assays | 2020 |